Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Optimising Outcomes in Patients with Hepatitis-Associated Aplastic Anaemia
1
Mins
March 2024
Exploring strategies to optimise outcomes for those with HAAA, and assessing both safety and efficacy of HSCT was the goal of an emerging piece of research.
Read more
1
Mins
29th March 2016
Hepatitis C Provides Potent Antiviral Molecules
RESISTANT viruses may soon face a potent new antiviral body in the form of the amphipathic α-helical (AH) peptide, a molecule found within the hepatitis…
1
Mins
29th March 2016
Team Discover Achilles’ Heel of Liver Cancer
DEADLY liver cancer may have met its match, with the discovery of stem cell markers in the biological makeup of hepatocellular carcinoma.
2
Mins
14th March 2016
Sneaking through Barrier Gaps: Gut Microbiota Imbalance Harms the Liver
March 14, 2016: The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions only. Prominent among the other organs…
1
Mins
19th February 2016
Introducing the European Medical Journal 1.1
United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.
2
Mins
8th December 2015
European Medicines Agency Validates Gilead’s Marketing Application for Investigational Fixed-Dose Combination of Sofosbuvir/Velpatasvir for the Treatment of Hepatitis C
Foster City, Calif., December 4, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its Marketing Authorization Application (MAA) for…
1
Mins
24th November 2015
SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms
SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…
7
Mins
16th November 2015
Multiple Scientific Presentations at the Liver Meeting 2015 Further Highlight the Utility of Sofosbuvir-Based Hepatitis C Therapies
San Francisco, November 14, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it will present 32 scientific presentations related to its…
4
Mins
12th October 2015
European Liver Patients’ Association (ELPA) Launches Call to Action Report for the Treatment of Hepatic Encephalopathy
BRUSSELS, BELGIUM, 12 October 2015, 18:30 CET – ELPA today launched a new call to action report ‘Time to DeLiver: Getting a Grip on HE’ at the…
Loading posts...
« Previous
1
…
11
12
13
14
15
Next »